MEI Pharma

Biotechnology ResearchUnited States51-200 Employees

LITS - The largest public equity vehicle built to unlock Litecoin's potential.

Lite Strategy (NASDAQ: LITS) conducts the leading Litecoin treasury strategy.

We accumulate pure LTC through active treasury management and concentrate holdings per share as the ultimate metric of shareholder value.

Our corporate focus is: increasing LTC exposure for our shareholders.

We continue our pharmaceutical operations while leveraging our public company structure and operational expertise to build the leading Litecoin treasury strategy.

We are not just another treasury company because Litecoin is not just another asset. We are the bridge between the people's currency and the millions who deserve access to it.

Sign up for free to view info

Email Format Employee directory